The data shows that the company's revenue and net profit increased further in the third quarter. Compared with the second quarter, the total operating income increased by 10.83%, and the net profit returned to the mother increased by 23.90%. Runda Medical said in the third quarterly report that the growth of the company's performance during the reporting period was mainly due to the effective control of the epidemic situation in Shanghai and other places, and the company's main business gradually resumed growth.
Steady operation to maintain the growth momentum.
For Runda Medical, East China is its base camp and main strategic deployment area. If the impact of sudden epidemic is excluded, Runda Medical may have a better performance in terms of the company's existing scale and operation mode.
According to the data, the company is one of the leading comprehensive service providers of in-hospital testing in China, and its main business is to deepen the in-hospital testing service market of public hospitals. In terms of commercial services, the company extended the Shanghai service business model to other parts of the country by expanding services, deepening the market and expanding the service platform market. In the field of industrial pipeline, the company has accelerated the laying of self-produced clinical mass spectrometer and new saccharification instrument, and has carried out in-depth cooperation with Orson, and will carry out in-depth cooperation in the detection fields such as immunodiagnosis.
Runda Medical, as a service platform enterprise, has now formed a scale advantage, which is an important factor for the company to recover quickly and return to a stable growth trend after the epidemic. According to the data, Runda Medical has provided professional in-vitro diagnostic products and technical service support for more than 4,000 medical institutions at all levels across the country, and the number of service customers ranks among the top in the same industry.
Conform to the development trend of new medical infrastructure
In recent years, under the general trend of new medical infrastructure, various policies to support the rapid development of medical institutions have been introduced one after another, and the momentum of hospital construction across the country is rapid, which has driven the rapid development of the industry.
The data shows that by the end of 20021,the new market space of medical infrastructure in China has reached 20 billion yuan; The market space brought by the Thousand County Project is expected to reach 654.38+0 billion yuan. Some time ago, the Standing Committee of the State Council and National Health Commission also issued policies to support relevant medical institutions to upgrade medical equipment with financial discount loans. It can be predicted that the new round of primary medical capacity upgrading will surely usher in greater benefits, benefit from new medical infrastructure, and encourage the purchase of domestic equipment. As a comprehensive service provider of medical inspection in public hospitals, Runda Medical will give full play to the advantages of inspection services and assist medical institutions to accelerate the improvement of regional medical service capabilities. At the same time, the new infrastructure has become the driving force for the digital transformation of the medical industry, and the new medical digital infrastructure will usher in good development opportunities. Runda Medical has been focusing on smart inspection, building a digital inspection platform, and developing a series of digital information products around smart medical care, smart service and smart management. The dimension of digital assistance service has jumped, and the traditional inspection medical service has been transformed and upgraded to lean and intelligent.
According to industry analysts, with the continuous development of diagnostic technology, the types of in-hospital inspection items are increasing, and there is still room for growth in the domestic clinical inspection market. As a leading comprehensive service provider of medical laboratories in China, Runda Medical will continue to meet the testing needs of customers in downstream medical institutions, which will become the endogenous driving force for the company's stable growth in future performance and is expected to continue to benefit.
Want to know more financial news in real time, please pay attention to us.